Ultragenyx Pharmaceutical (RARE) Depreciation & Amortization (CF) (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) reported Depreciation & Amortization (CF) of $8.0 million for Q1 2026, down 11.11% year-over-year from $9.0 million in Q1 2025, and down 8.94% on a QoQ basis from $8.8 million in Q4 2025.
Ultragenyx Pharmaceutical (RARE) has 14 years of Depreciation & Amortization (CF) data on file, last reported at $8.0 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 11.11% year-over-year to $8.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.0 million (down 5.96% YoY) and the FY2025 annual result came in at $35.0 million, down 2.78% from the prior year.
- Depreciation & Amortization (CF) declined to $8.0 million in Q1 2026 per RARE's latest filing, from $8.8 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $9.5 million in Q4 2024 and bottomed at $4.1 million in Q1 2022.
- The 5-year median for Depreciation & Amortization (CF) is $8.2 million (2023), against an average of $7.2 million.
- The widest annual swing landed in 2024, when Depreciation & Amortization (CF) surged 68.93%; it then fell 11.11% in 2026.
- Tracing RARE's Depreciation & Amortization (CF) over 5 years: stood at $5.0 million in 2022, then surged by 65.66% to $8.2 million in 2023, then climbed by 16.12% to $9.5 million in 2024, then decreased by 7.88% to $8.8 million in 2025, then dropped by 8.94% to $8.0 million in 2026.
- Per Business Quant, the three latest RARE Depreciation & Amortization (CF) figures stand at $8.0 million (Q1 2026), $8.8 million (Q4 2025), and $8.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | 8.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.00 Mn |
| Mar 31, 2026 | 8.00 Mn |
| Dec 31, 2025 | 8.79 Mn |
| Dec 31, 2025 | 8.79 Mn |
| Sep 30, 2025 | 8.61 Mn |
| Sep 30, 2025 | 8.61 Mn |
| Jun 30, 2025 | 8.61 Mn |
| Jun 30, 2025 | 8.61 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Dec 31, 2024 | 9.54 Mn |
| Dec 31, 2024 | 9.54 Mn |
| Sep 30, 2024 | 8.76 Mn |
| Sep 30, 2024 | 8.76 Mn |
| Jun 30, 2024 | 8.86 Mn |
| Jun 30, 2024 | 8.86 Mn |
| Mar 31, 2024 | 8.85 Mn |
| Mar 31, 2024 | 8.85 Mn |
| Dec 31, 2023 | 8.21 Mn |
| Dec 31, 2023 | 8.21 Mn |
| Sep 30, 2023 | 7.19 Mn |
| Sep 30, 2023 | 7.19 Mn |
| Jun 30, 2023 | 5.36 Mn |
| Jun 30, 2023 | 5.36 Mn |
| Mar 31, 2023 | 5.24 Mn |
| Mar 31, 2023 | 5.24 Mn |
| Dec 31, 2022 | 4.96 Mn |
| Dec 31, 2022 | 4.96 Mn |
| Sep 30, 2022 | 4.69 Mn |
| Sep 30, 2022 | 4.69 Mn |
| Jun 30, 2022 | 4.48 Mn |
| Jun 30, 2022 | 4.48 Mn |
| Mar 31, 2022 | 4.09 Mn |
| Mar 31, 2022 | 4.09 Mn |
| Dec 31, 2021 | 3.53 Mn |
| Dec 31, 2021 | 3.53 Mn |
| Sep 30, 2021 | 3.22 Mn |
| Sep 30, 2021 | 3.22 Mn |
| Jun 30, 2021 | 3.12 Mn |
| Jun 30, 2021 | 3.12 Mn |
| Mar 31, 2021 | 3.37 Mn |
| Mar 31, 2021 | 3.37 Mn |
| Dec 31, 2020 | 3.13 Mn |
| Dec 31, 2020 | 3.13 Mn |
| Sep 30, 2020 | 3.09 Mn |
| Sep 30, 2020 | 3.09 Mn |
| Jun 30, 2020 | 3.18 Mn |
| Jun 30, 2020 | 3.18 Mn |
| Mar 31, 2020 | 2.85 Mn |
| Mar 31, 2020 | 2.85 Mn |
| Dec 31, 2019 | 2.17 Mn |
| Dec 31, 2019 | 2.17 Mn |
| Sep 30, 2019 | 2.15 Mn |
| Sep 30, 2019 | 2.15 Mn |
| Jun 30, 2019 | 2.11 Mn |
| Jun 30, 2019 | 2.11 Mn |
| Mar 31, 2019 | 2.12 Mn |
| Mar 31, 2019 | 2.12 Mn |
| Dec 31, 2018 | 2.94 Mn |
| Dec 31, 2018 | 2.94 Mn |
| Sep 30, 2018 | 4.36 Mn |
| Sep 30, 2018 | 4.36 Mn |
| Jun 30, 2018 | 6.08 Mn |
| Jun 30, 2018 | 6.08 Mn |
| Mar 31, 2018 | 6.16 Mn |
| Mar 31, 2018 | 6.16 Mn |
| Dec 31, 2017 | 2.51 Mn |
| Dec 31, 2017 | 2.51 Mn |
| Sep 30, 2017 | 1.10 Mn |
| Sep 30, 2017 | 1.10 Mn |
| Jun 30, 2017 | 1.06 Mn |
| Jun 30, 2017 | 1.06 Mn |
| Mar 31, 2017 | 1.16 Mn |
| Mar 31, 2017 | 1.16 Mn |
| Dec 31, 2016 | 1.16 Mn |
| Dec 31, 2016 | 1.16 Mn |
| Sep 30, 2016 | 1.03 Mn |
| Sep 30, 2016 | 1.03 Mn |
| Jun 30, 2016 | 692,000.00 |
| Jun 30, 2016 | 692,000.00 |
| Mar 31, 2016 | 544,000.00 |
| Mar 31, 2016 | 544,000.00 |
| Dec 31, 2015 | 480,000.00 |
| Dec 31, 2015 | 480,000.00 |
| Sep 30, 2015 | 441,000.00 |
| Sep 30, 2015 | 441,000.00 |
| Jun 30, 2015 | 262,000.00 |
| Jun 30, 2015 | 262,000.00 |
| Mar 31, 2015 | 201,000.00 |
| Mar 31, 2015 | 201,000.00 |
| Dec 31, 2014 | 212,000.00 |
| Dec 31, 2014 | 212,000.00 |
| Sep 30, 2014 | 194,000.00 |
| Sep 30, 2014 | 194,000.00 |
| Jun 30, 2014 | 161,000.00 |
| Jun 30, 2014 | 161,000.00 |
| Mar 31, 2014 | 117,000.00 |
| Mar 31, 2014 | 117,000.00 |
| Dec 31, 2013 | 112,000.00 |
| Dec 31, 2013 | 112,000.00 |
| Sep 30, 2013 | 105,000.00 |
| Sep 30, 2013 | 105,000.00 |
| Jun 30, 2013 | 103,000.00 |
| Jun 30, 2013 | 103,000.00 |
| Mar 31, 2013 | 124,000.00 |
| Mar 31, 2013 | 124,000.00 |